Login / Signup

Authors Reply to Letter to the Editor - In Response to Comment on Raul E. Ruiz-Lozano et al.'s "Predictive Factors for the Prognosis of Vogt-Koyanagi-Harada Disease".

Pınar KayaMerve İnanç TekinPinar Cakar Ozdal
Published in: Ocular immunology and inflammation (2023)
An aggressive treatment, including immunomodulatory therapy, is very important in preventing the development of the chronic recurrent stage in Vogt-Koyanagı-Harada (VKH) disease. However, the way of treatment is not the only factor determining the prognosis, and there are other factors that affect the outcome.
Keyphrases
  • stem cells
  • bone marrow